Sysmex France
Menu

Promoting Business Process Restructuring through Digitalization to Reinforce Corporate Foundations and Create New Value

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) is promoting globally a business process restructuring through digitalization, in an effort to reinforce its corporate foundations and create new value. To achieve business process restructuring, we will construct a digital foundation for the corporate management functions that underpin the Group management foundation, as well as for the value chain encompassing research and development, procurement and logistics, manufacturing, and sales and service.

The onward march of digital technologies, as exemplified by the Internet of Things (IoT), is making it possible to accumulate a wide variety of a host of data. Recently, this massive amount of accumulated data is being analyzed using artificial intelligence (AI), and robotic process automation is rapidly being used to automate standardized operations. This use of these new technologies to digitalize business processes is expected to contribute significantly to decision-making in corporate management, productivity increases in operations, and the generation of value such as through the creation of new services.

To promote globally a business process restructuring in the aim of reinforcing its corporate foundations and creating new value, Sysmex is putting in place a next-generation core system and renovating its digital basis. In addition to centering on the accounting and finance, with this business process restructuring through digitalization Sysmex is targeting a wide range of process reforms spanning research and development, procurement and logistics, manufacturing, sales and service, and human resource management. To implement business process restructuring measures, the Company is partnering with SAP Japan Co., Ltd. (HQ: Tokyo, Japan; President: Yuzuru Fukuda) and EY Advisory & Consulting Co., Ltd. (HQ: Tokyo, Japan; President: Masahiko Tsukahara), making practical use of their solutions and knowhow to promote effectiveness.

Through these initiatives, Sysmex will reinforce its information security and other aspects of the corporate infrastructure and aims to understand the status of management across the Group in real time, boost business efficiency by linking product information consistently across the value chain, shorten the product supply lead time, reduce raw materials expenses and days in inventory turnover, and otherwise enhance productivity through the optimization of operations. Furthermore, by linking information for individual processes in the value chain we seek to efficiently develop and launch new products and services. We will also provide added value through links between the digital basis and the Caresphere™ network solution to contribute to the medical economy by supporting efficient operations at hospitals and laboratories.

By aiming to create new diagnostic value through the restructuring of business processes through digitalization, Sysmex will contribute to the development of healthcare and the healthy lives of people.
 

Overview of the Digitalization Plan

Implementation period: From October 2018 to March 2022
Investment: Approximately ¥17.0 billion
Partners:

 

  • SAP Japan Co., Ltd.

            Provision of core systems and other best-practice solutions, as well as implementation support

 

  • EY Advisory & Consulting Co., Ltd.

            Configuration and introduction of SAP solutions and support for business process restructuring


*Information contained in the press release is current as of the date of the announcement, but may be subject to change without prior notice.
 

Back to overview
Copyright © Sysmex Europe GmbH. All rights reserved.
Information

Nous informons les visiteurs que ce site Internet est, uniquement, à destination des professionnels de santé (*)
Merci de confirmer que vous êtes un professionnel de santé (*)

(*) Un professionnel de santé est défini comme toute personne habilitée à prescrire, dispenser ou utiliser des DMDIV (Dispositifs Médicaux de Diagnostic In Vitro) dans l’exercice de son art.

Excusez-nous.

Cette page est réservée aux professionnels. Ils ne sont pas autorisés.

Personnalisez vos paramètres

Nous utilisons des cookies pour vous permettre une utilisation optimale de notre site web et pour améliorer notre communication avec vous. Nous tenons compte de vos choix et nous n’utilisons que les données pour lesquelles vous nous donnez votre consentement.

* Peut conduire à des restrictions dans les contenus et l’expérience d’utilisateur
Détails sur les cookies
Cookies strictement nécessaires
Ces cookies contribuent à l’exploitation de notre site web en autorisant des fonctions de base, telles que la navigation sur le site et l’accès à des zones sécurisées de notre site web. Notre site web ne peut pas fonctionner correctement sans ces cookies.
Cookies de statistiques
Ces cookies nous aident à comprendre comment des visiteurs interagissent avec notre site web, en récoltant des informations de façon anonyme. Ces informations nous permettent d’améliorer constamment notre offre.
Cookies marketing
Ils sont utilisés pour tracer des visiteurs sur des sites web. Ils ont pour objet de montrer des annonces pertinentes et attractives à chaque utilisateur et donc précieuses pour les éditeurs et les annonceurs tiers.